Registro:

Referencias:

• Babasaki, K., Takao, T., Shimonishi, Y., Kurahashi, K., Subtilosin A, a new antibiotic peptide produced by Bacillus subtilis: isolation, structural analysis, and biogenesis (1985) J Biochem, 98, pp. 585-603
• Belshe, R.B., Leone, P.A., Bernstein, D.I., Wald, A., Levin, M.J., Stapleton, J.T., Gorfinkel, I., Morrow, R.L., Efficacy results of a trial of a herpes simplex vaccine (2012) N Engl J Med, 366, pp. 34-43
• Chentoufi, A.A., Benmohamed, L., Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections (2012) Clin Dev Immunol, 2012, p. 149135
• Chilukuri, S., Rosen, T., Management of acyclovir-resistant herpes simplex virus (2003) Dermatol Clin, 21, pp. 311-320
• Choong, K., Walker, N., Apel, A., Whitby, M., (2010) Aciclovir-resistant herpes keratitis. Clin Experiment Ophtalmol, 38, pp. 309-313
• Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival (1986) J Immunol Methods, 89, pp. 271-277
• Des Jarlais, D.C., Arasteh, K., McKnight, C., Perlman, D.C., Feelemyer, J., Hagan, H., Cooper, H.L., HSV-2 Co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City (2014) PLoS ONE, 9, p. e87993
• Efstathiou, S., Preston, C.M., Towards an understanding of the molecular basis of herpes simplex virus latency (2005) Virus Res, 111, pp. 108-119
• Férir, G., Petrova, M.I., Andrei, G., Huskens, D., Hoorelbeke, B., Snoeck, R., Vanderleyden, J., Balzarini, J., The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications (2013) PLoS ONE, 8, p. e64010
• Fife, K.H., Warren, T.J., Justus, S.E., Heitman, C.K., An international, randomized, double-blind, placebo controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients (2008) Sex Transm Dis, 35, pp. 666-673
• Freeman, E.E., Weiss, H.A., Glynn, J.R., Cross, P.L., Whitworth, J.A., Hayes, R.J., Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies (2006) AIDS, 20, pp. 73-83
• Gottlieb, S.L., Low, N., Newman, L.M., Bolan, G., Kamb, M., Broutet, N., Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines (2014) Vaccine, 32, pp. 1527-1535
• Johnston, C., Saracino, M., Kuntz, S., Magaret, A., Selke, S., Huang, M.L., Schiffer, J.T., Koelle, D.M., Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials (2012) Lancet, 379, pp. 641-647
• van Kuijk, S., Noll, K.S., Chikindas, M.L., The species-specific mode of action of the antimicrobial peptide subtilosin against Listeria monocytogenes Scott A (2012) Lett Appl Microbiol, 54, pp. 52-58
• Marx, R., Stein, T., Entian, K.D., Glaser, S.J., Structure of the Bacillus subtillis peptide antibiotic subtilosin A determined by 1H NMR and matrix assisted laser desorption/ionization time-of-flight mass spectrometry (2001) J Protein Chem, 20, pp. 501-506
• Noll, K.S., Prichard, M.N., Khaykin, A., Sinko, P.J., Chikindas, M.L., The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli (2012) Antimicrob Agents Chemother, 56, pp. 1756-1761
• Saeed, S., Rasool, S.A., Ahmad, S., Zaidi, S.Z., Rehmani, S., Antiviral activity of staphylococcin 188: a purified bacteriocin like inhibitory substance isolated from Staphylococcus aureus AB188 (2007) Res J Microbiol, 2, pp. 796-806
• Serkedjieva, J., Danova, S., Ivanova, I., Antiinfluenza virus activity of a bacteriocin produced by Lactobacillus delbrueckii (2000) Appl Biochem Biotechnol, 88, pp. 285-298
• Sutyak, K.E., Anderson, R.A., Dover, S.E., Feathergill, K.A., Aroutcheva, A.A., Faro, S., Chikindas, M.L., Spermicidal activity of the safe natural antimicrobial peptide subtilosin (2008) Infect Dis Obstet Gynecol, 2008, p. 540758
• Sutyak, K.E., Wirawan, R.E., Aroutcheva, A.A., Chikindas, M.L., Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens (2008) J Appl Microbiol, 104, pp. 1067-1074
• Thurman, A.R., Doncel, G.F., Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention (2012) Int J STD AIDS, 23, pp. 613-619
• Todorov, S.D., Wachsman, M.B., Knoetze, H., Meincken, M., Dicks, L.M., An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans (2005) Int J Antimicrob Agents, 25, pp. 508-513
• Todorov, S.D., Wachsman, M., Tomé, E., Dousset, X., Destro, M.T., Dicks, L.M., Franco, B.D., Vaz-Velho, M., Characterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium (2010) Food Microbiol, 27, pp. 869-879
• Torres, N.I., Noll, K.S., Xu, S., Li, J., Huang, Q., Sinko, P.J., Wachsman, M.B., Chikindas, M.L., Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1 (2013) Probiotics Antimicrob Proteins, 5, pp. 26-35
• Turovskiy, Y., Cheryian, T., Algburi, A., Wirawan, R.E., Takhistov, P., Sinko, P.J., Chikindas, M.L., Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester (2012) Infect Dis Obstet Gynecol, 2012, p. 284762
• van Velzen, M., van Loenen, F.B., Meesters, R.J., de Graaf, M., Remeijer, L., Luider, T.M., Osterhaus, A.D., Verjans, G.M., Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals (2012) J Infect Dis, 205, pp. 1539-1543
• Wachsman, M.B., Farías, M.E., Takeda, E., Sesma, F., de Ruiz Holgado, A.P., de Torres, R.A., Coto, C.E., Antiviral activity of enterocin CRL35 against herpesviruses (1999) Int J Antimicrob Agents, 12, pp. 293-299
• Wachsman, M.B., Castilla, V., de Ruiz Holgado, A.P., de Torres, R.A., Sesma, F., Coto, C.E., Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro (2003) Antiviral Res, 58, pp. 17-24
• Wald, A., Corey, L., Timmler, B., Magaret, A., Warren, T., Tyring, S., Johnston, C., Kriesel, J., Helicase-primase inhibitor pritelivir for HSV-2 infection (2014) N Engl J Med, 370, pp. 201-210

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------